Guiding the Path of Treatment for Individual Cancer Patients


PraediCare Dx™

Eutropics is advancing personalized medicine by providing novel, predictive diagnostic tests that are uniquely accurate in guiding patient cancer treatments.

» Innovative leading cancer treatment response predictors

» Demonstrated medical utility in blood cancers

» CLIA certified tests for Acute Myeloid Leukemia

» Validated tests for Chronic Lymphocytic Leukemia